The Effectiveness of Different Pulse Duration of NMES in Patients With Pyramidal Tract-related Spasticity Measured by Neurophysiological Tools

NCT ID: NCT07321158

Last Updated: 2026-01-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-06

Study Completion Date

2026-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Spasticity is a common symptom that affects more than 50% of patients with upper motor neuron lesions due to damage on pyramidal tract. Despite the current pharmacological and physical therapy rehabilitation methods, previous studies have highlighted the beneficial role of Neuromuscular Electrical Stimulation (NMES) on managing upper limb spasticity. However, due to heterogeneity of application parameters there is a lack of a standardized protocol for spasticity management. The aim of the study will be to examine the effects of high versus low pulse duration neuromuscular electrical stimulation on upper limb spasticity on patients with pyramidal tract-related spasticity.

A total of 45 patients will be randomized (1:1:1 ratio) to either high pulse duration NMES (HPD-NMES) or low pulse duration NMES (LPD-NMES) or Control group, receiving the standard of care. Randomization will be performed by an independent investigator, who will allocate participants to one of three groups, using a random number generator, prior to baseline assessment. Each group will receive a 15min-conventional-physiotherapeutic protocol. HPD-NMES and LPD-NMES will receive an additional 30min-NMES protocol of high and low pulse duration, respectively. Pre and post intervention spasticity will be evaluated using Range of Motion (ROM) of the elbow joint through electronic goniometer, Modified Ashworth Scale (MAS) and surface electromyography (EMG). Furthermore, Modified Barthel Index (MBI) and 12-version of World Health Organization Disability Assessment Schedule (WHODAs) will be used for evaluating participants' quality of life. Statistical analysis will aim to highlight the effects of NMES both on the EMG-electrophysiological parameters and on clinical evaluation scales. Additionally, it will seek to determine which of the two NMES pulse durations produced more beneficial results in reducing spasticity levels.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Spasticity can be characterized as a clinical phenotype related to upper motor neuron syndrome and is highly correlated with pyramidal tract lesions, leading to patients' quality of life degradation. The assessment of spasticity encompasses both clinical rating scales (such as Modified Ashworh Scale, Modified Tardieu Scale and Composite Spasticity Scale) and neurophysiological approaches through surface electromyography (such as Hoffmann reflex (H-reflex) , Mwave, and Hmax/Mmax ratio (or M/H amplitude ratio), which seem to be elevated in spasticity. A wide spectrum of therapeutic modalities, including pharmacological and non-pharmacological interventions, have been developed for the management of spasticity. Among non-pharmacological interventions, physical therapy through Neuromuscular Electrical Stimulation can be used to manage upper and lower limb spasticity through the reduction of stretch reflex excitability, facilitation reciprocal inhibition and spinal excitability modulation.

This randomized controlled trial consists of:

* Participants randomization into one control group (group A, n=15) and two intervention groups: group B (High Pulse Duration Neuromuscular Electrical Stimulation/HPD-NMES, n=15), group C (Low Pulse Duration Neuromuscular Electrical Stimulation/LPD-NMES, n=15).
* Conventional Physiotherapy training program for 15 minutes per session, 3 times per week for 6 weeks total (groups A, B,C) and Neuromuscular Electrical Stimulation protocol for 30 minutes per session, 3 times per week for 6 weeks total (Group B=HPD-NMES and Group C=LPD-NMES)
* Primary spasticity evaluation tool at baseline and post intervention (6weeks) through surface electromyography.
* Secondary spasticity evaluation tools (Modified Ashworth Scale/MAS, Range of Motion/ROM, Modified Barthel Index/MBI and 12 version World Health Organization Disability Assessment Schedule 2.0/ WHODAS 2.0) at baseline and post-intervention (6 weeks).

Statistical analysis will aim to highlight the effects of NMES both on the EMG-electrophysiological parameters and on clinical evaluation scales. Additionally, it will seek to determine which of the two NMES pulse durations produced more beneficial results in reducing spasticity levels.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pyramidal Tract-related Spasticity Upper Motor Neuron Lesion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High Pulse Duration Neuromuscular Electrical Stimulation (HPD-NMES)

Participants will receive 15 minutes Conventional physiotherapy training program (same as control group) and 30 minutes High Pulse Duration Neuromuscular Electrical Stimulation (HPD-NMES)

Group Type EXPERIMENTAL

Usual Care Group

Intervention Type OTHER

Conventional physiotherapy training program

* Seated upper extremity program, single limb exercises, strength training, stretching training (with or without) external resistance, Neurofacilitatory techniques (ie. Propriocetive Neuromuscular Facilitation (PNF), NeuroDevelopmental Treatment- Bobath (NDT-Bobath) etc)
* Treatment Duration: 15minutes per session, 3 times per week for 6 weeks total.

High Pulse Duration Neuromuscular Electrical Stimulation Group

Intervention Type DEVICE

30 minutes High Pulse Duration Neuromuscular Electrical Stimulation (HPD-NMES)

* NMES Application Parameters:

* Waveform: rectangular, biphasic. Symmetrical
* Pulse Duration:450μsec
* Frequency: 100Hz
* Intensity: Optical muscle contraction and patients' tolerability
* Ramp up: 2sec
* Ramp down:2sec
* ON/OFFtime: 10sec/30sec (1:3)
* Treatment Duration: 30 minutes per session, 3 times per week for 6 weeks total.

Low Pulse Duration Neuromuscular Electrical Stimulation (LPD-NMES)

Participants will receive 15 minutes Conventional physiotherapy training program (same as control group) and 30 minutes Low Pulse Duration Neuromuscular Electrical Stimulation (LPD-NMES)

Group Type EXPERIMENTAL

Usual Care Group

Intervention Type OTHER

Conventional physiotherapy training program

* Seated upper extremity program, single limb exercises, strength training, stretching training (with or without) external resistance, Neurofacilitatory techniques (ie. Propriocetive Neuromuscular Facilitation (PNF), NeuroDevelopmental Treatment- Bobath (NDT-Bobath) etc)
* Treatment Duration: 15minutes per session, 3 times per week for 6 weeks total.

Low Pulse Duration Neuromuscular Electrical Stimulation Group

Intervention Type DEVICE

30 minutes Low Pulse Duration Neuromuscular Electrical Stimulation (LPD-NMES)

* NMES Application Parameters:

* Waveform: rectangular, biphasic. Symmetrical
* Pulse Duration:100μsec
* Frequency: 100Hz
* Intensity: Optical muscle contraction and patients' tolerability
* Ramp up: 2sec
* Ramp down:2sec
* ON/OFFtime: 10sec/30sec (1:3)
* Treatment Duration: 30 minutes per session, 3 times per week for 6 weeks total.

Control

Patients will receive 15 minute conventional physiotherapy training program that includes seated upper extremity program, single limb exercises, strength training, stretching training (with or without) external resistance, Neurofacilitatory techniques (ie. Propriocepive Neuromuscular Facilitation (PNF), NeuroDevelopmental Treatment -Bobath (NDT-Bobath) etc)

Group Type OTHER

Usual Care Group

Intervention Type OTHER

Conventional physiotherapy training program

* Seated upper extremity program, single limb exercises, strength training, stretching training (with or without) external resistance, Neurofacilitatory techniques (ie. Propriocetive Neuromuscular Facilitation (PNF), NeuroDevelopmental Treatment- Bobath (NDT-Bobath) etc)
* Treatment Duration: 15minutes per session, 3 times per week for 6 weeks total.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Usual Care Group

Conventional physiotherapy training program

* Seated upper extremity program, single limb exercises, strength training, stretching training (with or without) external resistance, Neurofacilitatory techniques (ie. Propriocetive Neuromuscular Facilitation (PNF), NeuroDevelopmental Treatment- Bobath (NDT-Bobath) etc)
* Treatment Duration: 15minutes per session, 3 times per week for 6 weeks total.

Intervention Type OTHER

High Pulse Duration Neuromuscular Electrical Stimulation Group

30 minutes High Pulse Duration Neuromuscular Electrical Stimulation (HPD-NMES)

* NMES Application Parameters:

* Waveform: rectangular, biphasic. Symmetrical
* Pulse Duration:450μsec
* Frequency: 100Hz
* Intensity: Optical muscle contraction and patients' tolerability
* Ramp up: 2sec
* Ramp down:2sec
* ON/OFFtime: 10sec/30sec (1:3)
* Treatment Duration: 30 minutes per session, 3 times per week for 6 weeks total.

Intervention Type DEVICE

Low Pulse Duration Neuromuscular Electrical Stimulation Group

30 minutes Low Pulse Duration Neuromuscular Electrical Stimulation (LPD-NMES)

* NMES Application Parameters:

* Waveform: rectangular, biphasic. Symmetrical
* Pulse Duration:100μsec
* Frequency: 100Hz
* Intensity: Optical muscle contraction and patients' tolerability
* Ramp up: 2sec
* Ramp down:2sec
* ON/OFFtime: 10sec/30sec (1:3)
* Treatment Duration: 30 minutes per session, 3 times per week for 6 weeks total.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

HPD-NMES LPD-NMES Control Group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* diagnosis by neurologist with first damage of pyramidal tract with upper limb spasticity
* absence of cognitive dysfunction
* normal vital signs

Exclusion Criteria

* prior neurological damage to pyramidal tract
* cognitive decline
* dermatological damages
* prior musculoskeletal dysfunction on the upper limb with spasticity
* presence of metallic residues on the spastic upper limb
* presence of seizures or psychiatric disorders
* severe malformation or obesity (BMI \>30kg/m2)
* history of coronary or other cardiovascular diseases (deep vein thrombosis, pulmonary embolism)
* presence of systematic inflammatory disease
* cancer on terminal stages
* pregnancy.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Attikon Hospital

OTHER

Sponsor Role collaborator

University of West Attica

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Athanasios K. Chasiotis

Physiotherapist, MSc, PHDc

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Athanasios K. Chasiotis, Physiotherapist

Role: CONTACT

References

Explore related publications, articles, or registry entries linked to this study.

Chasiotis AK, Giannopapas V, Papadopoulou M, Panagopoulos T, Stasinopoulos D, Giannopoulos S, Bakalidou D. High-Frequency Transcutaneous Electrical Nerve Stimulation in the Management of Pyramidal Tract-Related Spasticity: A Systematic Review. Cureus. 2025 Jun 18;17(6):e86298. doi: 10.7759/cureus.86298. eCollection 2025 Jun.

Reference Type BACKGROUND
PMID: 40688884 (View on PubMed)

Chasiotis A, Giannopapas V, Papadopoulou M, Chondrogianni M, Stasinopoulos D, Giannopoulos S, Bakalidou D. The Effect of Neuromuscular Electrical Nerve Stimulation in the Management of Post-stroke Spasticity: A Scoping Review. Cureus. 2022 Nov 29;14(11):e32001. doi: 10.7759/cureus.32001. eCollection 2022 Nov.

Reference Type BACKGROUND
PMID: 36600817 (View on PubMed)

Kai S, Nakabayashi K. Evoked EMG Makes Measurement of Muscle Tone Possible by Analysis of the H/M Ratio. [Internet]. Electrodiagnosis in New Frontiers of Clinical Research. InTech; 2013; doi: 10.5772/55783.

Reference Type BACKGROUND

Kunoh K, Takenaka T, Kimura D, Suzuki T. Unilateral Vibration Stimulation in Patients With Post-stroke Spasticity Suppresses Muscle Tonus in the Contralateral Homologous Muscles. Cureus. 2025 Aug 31;17(8):e91360. doi: 10.7759/cureus.91360. eCollection 2025 Aug.

Reference Type BACKGROUND
PMID: 41041108 (View on PubMed)

Tekgul H, Polat M, Tosun A, Serdaroglu G, Gokben S. Electrophysiologic assessment of spasticity in children using H-reflex. Turk J Pediatr. 2013 Sep-Oct;55(5):519-23.

Reference Type BACKGROUND
PMID: 24382533 (View on PubMed)

Papavasileiou A, Xenofondos A, Baudry S, Lapole T, Amiridis IG, Metaxiotis D, Tsatalas T, Patikas DA. Protocols Targeting Afferent Pathways via Neuromuscular Electrical Stimulation for the Plantar Flexors: A Systematic Review. Sensors (Basel). 2023 Feb 20;23(4):2347. doi: 10.3390/s23042347.

Reference Type BACKGROUND
PMID: 36850945 (View on PubMed)

Scalia M, Borzuola R, Parrella M, Borriello G, Sica F, Monteleone F, Macaluso A. Neuromuscular electrical stimulation reduces spinal excitability in Multiple Sclerosis patients with spasticity symptoms. Mult Scler Relat Disord. 2025 Jul;99:106457. doi: 10.1016/j.msard.2025.106457. Epub 2025 Apr 19.

Reference Type BACKGROUND
PMID: 40286626 (View on PubMed)

Ferfeli S, Galanos A, Dontas IA, Triantafyllou A, Triantafyllopoulos IK, Chronopoulos E. Reliability and validity of the Greek adaptation of the Modified Barthel Index in neurorehabilitation patients. Eur J Phys Rehabil Med. 2024 Feb;60(1):44-54. doi: 10.23736/S1973-9087.23.08056-5. Epub 2023 Oct 25.

Reference Type BACKGROUND
PMID: 37877957 (View on PubMed)

Papadopoulou, M., Stasi, S., Bakalidou, D. et al. Psychometric Properties of the 12-Item World Health Organization Disability Assessment Schedule (WHODAS 2.0) in Adult Patients with Motor Disabilities. J Dev Phys Disabil 32, 801-819 (2020). https://doi.org/10.1007/s10882-019-09721-0

Reference Type BACKGROUND

Voerman GE, Fleuren JF, Kallenberg LA, Rietman JS, Snoek GJ, Hermens HJ. Patient ratings of spasticity during daily activities are only marginally associated with long-term surface electromyography. J Neurol Neurosurg Psychiatry. 2009 Feb;80(2):175-81. doi: 10.1136/jnnp.2008.147090. Epub 2008 Oct 23.

Reference Type BACKGROUND
PMID: 18948361 (View on PubMed)

Burridge JH, Wood DE, Hermens HJ, Voerman GE, Johnson GR, van Wijck F, Platz T, Gregoric M, Hitchcock R, Pandyan AD. Theoretical and methodological considerations in the measurement of spasticity. Disabil Rehabil. 2005 Jan 7-21;27(1-2):69-80. doi: 10.1080/09638280400014592.

Reference Type BACKGROUND
PMID: 15799144 (View on PubMed)

Nakipoglu Yuzer GF, Kose Donmez B, Ozgirgin N. A Randomized Controlled Study: Effectiveness of Functional Electrical Stimulation on Wrist and Finger Flexor Spasticity in Hemiplegia. J Stroke Cerebrovasc Dis. 2017 Jul;26(7):1467-1471. doi: 10.1016/j.jstrokecerebrovasdis.2017.03.011. Epub 2017 Apr 24.

Reference Type BACKGROUND
PMID: 28462794 (View on PubMed)

He YL, Gao Y, Fan BY. Effectiveness of neuromuscular electrical stimulation combined with rehabilitation training for treatment of post-stroke limb spasticity. Medicine (Baltimore). 2019 Sep;98(39):e17261. doi: 10.1097/MD.0000000000017261.

Reference Type BACKGROUND
PMID: 31574840 (View on PubMed)

Allen, K., Goodman, C. Using Electrical Stimulation: A Guideline for Allied Health Professionals [Internet]. New South Wales, Australia: Sydney Local Health District and Royal Rehabilitation Centre; 2014. Report No.: Clinical Guideline; https://www.alliedhealthsupport.com/wp-content/uploads/2019/03/Using-Electrical-Stimulation_A-guideline-for-allied-health-professionals-January-2014.pdf

Reference Type BACKGROUND

Doucet BM, Lam A, Griffin L. Neuromuscular electrical stimulation for skeletal muscle function. Yale J Biol Med. 2012 Jun;85(2):201-15. Epub 2012 Jun 25.

Reference Type BACKGROUND
PMID: 22737049 (View on PubMed)

Nussbaum EL, Houghton P, Anthony J, Rennie S, Shay BL, Hoens AM. Neuromuscular Electrical Stimulation for Treatment of Muscle Impairment: Critical Review and Recommendations for Clinical Practice. Physiother Can. 2017;69(5):1-76. doi: 10.3138/ptc.2015-88.

Reference Type BACKGROUND
PMID: 29162949 (View on PubMed)

Hsu SS, Hu MH, Luh JJ, Wang YH, Yip PK, Hsieh CL. Dosage of neuromuscular electrical stimulation: is it a determinant of upper limb functional improvement in stroke patients? J Rehabil Med. 2012 Feb;44(2):125-30. doi: 10.2340/16501977-0917.

Reference Type BACKGROUND
PMID: 22266658 (View on PubMed)

Reed B. The Physiology of Neuromuscular Electrical Stimulation: Pediatr Phys Ther. 1997;9(3):96???102; doi: 10.1097/00001577-199700930-00002.

Reference Type BACKGROUND

Castel-Lacanal E. Sites of electrical stimulation used in neurology. Ann Phys Rehabil Med. 2015 Sep;58(4):201-207. doi: 10.1016/j.rehab.2015.05.004. Epub 2015 Jul 14.

Reference Type BACKGROUND
PMID: 26183200 (View on PubMed)

Amiridis IG, Mani D, Almuklass A, Matkowski B, Gould JR, Enoka RM. Modulation of motor unit activity in biceps brachii by neuromuscular electrical stimulation applied to the contralateral arm. J Appl Physiol (1985). 2015 Jun 15;118(12):1544-52. doi: 10.1152/japplphysiol.00031.2015. Epub 2015 Apr 30.

Reference Type BACKGROUND
PMID: 25930023 (View on PubMed)

Stowe AM, Hughes-Zahner L, Barnes VK, Herbelin LL, Schindler-Ivens SM, Quaney BM. A pilot study to measure upper extremity H-reflexes following neuromuscular electrical stimulation therapy after stroke. Neurosci Lett. 2013 Feb 22;535:1-6. doi: 10.1016/j.neulet.2012.11.063. Epub 2013 Jan 8.

Reference Type BACKGROUND
PMID: 23313593 (View on PubMed)

Xie T, Leng Y, Zhi Y, Jiang C, Tian N, Luo Z, Yu H, Song R. Increased Muscle Activity Accompanying With Decreased Complexity as Spasticity Appears: High-Density EMG-Based Case Studies on Stroke Patients. Front Bioeng Biotechnol. 2020 Nov 16;8:589321. doi: 10.3389/fbioe.2020.589321. eCollection 2020.

Reference Type BACKGROUND
PMID: 33313042 (View on PubMed)

King TI II. The effect of neuromuscular electrical stimulation in reducing tone. Am J Occup Ther. 1996 Jan;50(1):62-4. doi: 10.5014/ajot.50.1.62. No abstract available.

Reference Type BACKGROUND
PMID: 8644838 (View on PubMed)

Clair-Auger JM, Collins DF, Dewald JP. The effects of wide pulse neuromuscular electrical stimulation on elbow flexion torque in individuals with chronic hemiparetic stroke. Clin Neurophysiol. 2012 Nov;123(11):2247-55. doi: 10.1016/j.clinph.2012.04.024. Epub 2012 May 22.

Reference Type BACKGROUND
PMID: 22627022 (View on PubMed)

Malhotra S, Rosewilliam S, Hermens H, Roffe C, Jones P, Pandyan AD. A randomized controlled trial of surface neuromuscular electrical stimulation applied early after acute stroke: effects on wrist pain, spasticity and contractures. Clin Rehabil. 2013 Jul;27(7):579-90. doi: 10.1177/0269215512464502. Epub 2012 Nov 5.

Reference Type BACKGROUND
PMID: 23129814 (View on PubMed)

Sahin N, Ugurlu H, Albayrak I. The efficacy of electrical stimulation in reducing the post-stroke spasticity: a randomized controlled study. Disabil Rehabil. 2012;34(2):151-6. doi: 10.3109/09638288.2011.593679. Epub 2011 Oct 15.

Reference Type BACKGROUND
PMID: 21999668 (View on PubMed)

Stein C, Fritsch CG, Robinson C, Sbruzzi G, Plentz RD. Effects of Electrical Stimulation in Spastic Muscles After Stroke: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Stroke. 2015 Aug;46(8):2197-205. doi: 10.1161/STROKEAHA.115.009633. Epub 2015 Jul 14.

Reference Type BACKGROUND
PMID: 26173724 (View on PubMed)

Takeda K, Tanino G, Miyasaka H. Review of devices used in neuromuscular electrical stimulation for stroke rehabilitation. Med Devices (Auckl). 2017 Aug 24;10:207-213. doi: 10.2147/MDER.S123464. eCollection 2017.

Reference Type BACKGROUND
PMID: 28883745 (View on PubMed)

Huang Y, Nam C, Li W, Rong W, Xie Y, Liu Y et al. A comparison of the rehabilitation effectiveness of neuromuscular electrical stimulation robotic hand training and pure robotic hand training after stroke: A randomized controlled trial. Biomedical Signal Processing and Control. 2020 Feb;56:101723. doi: 10.1016/j.bspc.2019.101723

Reference Type BACKGROUND

Sheffler LR, Chae J. Neuromuscular electrical stimulation in neurorehabilitation. Muscle Nerve. 2007 May;35(5):562-90. doi: 10.1002/mus.20758.

Reference Type BACKGROUND
PMID: 17299744 (View on PubMed)

Francisco GE, McGuire JR. Poststroke spasticity management. Stroke. 2012 Nov;43(11):3132-6. doi: 10.1161/STROKEAHA.111.639831. Epub 2012 Sep 13. No abstract available.

Reference Type BACKGROUND
PMID: 22984012 (View on PubMed)

Picelli A, Tamburin S, Gajofatto F, Zanette G, Praitano M, Saltuari L, Corradini C, Smania N. Association between severe upper limb spasticity and brain lesion location in stroke patients. Biomed Res Int. 2014;2014:162754. doi: 10.1155/2014/162754. Epub 2014 May 25.

Reference Type BACKGROUND
PMID: 24963473 (View on PubMed)

Lance JW. The control of muscle tone, reflexes, and movement: Robert Wartenberg Lecture. Neurology. 1980 Dec;30(12):1303-13. doi: 10.1212/wnl.30.12.1303. No abstract available.

Reference Type BACKGROUND
PMID: 7192811 (View on PubMed)

Lohia A, McKenzie J. Neuroanatomy, Pyramidal Tract Lesions. 2023 Jul 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK540976/

Reference Type BACKGROUND
PMID: 31082020 (View on PubMed)

Cho MJ, Yeo SS, Lee SJ, Jang SH. Correlation between spasticity and corticospinal/corticoreticular tract status in stroke patients after early stage. Medicine (Baltimore). 2023 Apr 25;102(17):e33604. doi: 10.1097/MD.0000000000033604.

Reference Type BACKGROUND
PMID: 37115067 (View on PubMed)

Lee D, Song J, Kim JW, Ahn TB. Spasticity secondary to isolated involvement of the pyramidal tract. J Neurol Sci. 2016 Sep 15;368:130-1. doi: 10.1016/j.jns.2016.06.072. Epub 2016 Jul 1. No abstract available.

Reference Type BACKGROUND
PMID: 27538615 (View on PubMed)

de Oliveira-Souza R. Damage to the pyramidal tracts is necessary and sufficient for the production of the pyramidal syndrome in man. Med Hypotheses. 2015 Jul;85(1):99-110. doi: 10.1016/j.mehy.2015.04.007. Epub 2015 Apr 29.

Reference Type BACKGROUND
PMID: 25959865 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

41389/06-05-2025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

NMES Efficacy on Patients With NBPP
NCT01999465 COMPLETED NA